These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Discrimination of multiple primary lung cancers from intrapulmonary metastasis based on the expression of four cancer-related proteins. Ono K, Sugio K, Uramoto H, Baba T, Ichiki Y, Takenoyama M, Hanagiri T, Oyama T, Yasumoto K. Cancer; 2009 Aug 01; 115(15):3489-500. PubMed ID: 19452548 [Abstract] [Full Text] [Related]
9. Clinicopathology and genetic profile of synchronous multiple small adenocarcinomas: implication for surgical treatment of an uncommon lung malignancy. Lin MW, Wu CT, Kuo SW, Chang YL, Yang PC. Ann Surg Oncol; 2014 Aug 01; 21(8):2555-62. PubMed ID: 24643899 [Abstract] [Full Text] [Related]
12. Carcinogen exposure, p53 alteration, and K-ras mutation in synchronous multiple primary lung carcinoma. Wang X, Christiani DC, Mark EJ, Nelson H, Wiencke JK, Gunn L, Wain JC, Kelsey KT. Cancer; 1999 Apr 15; 85(8):1734-9. PubMed ID: 10223567 [Abstract] [Full Text] [Related]
13. Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract. Chung KY, Mukhopadhyay T, Kim J, Casson A, Ro JY, Goepfert H, Hong WK, Roth JA. Cancer Res; 1993 Apr 01; 53(7):1676-83. PubMed ID: 8453641 [Abstract] [Full Text] [Related]
14. High frequency of clonally related tumors in cases of multiple synchronous lung cancers as revealed by molecular diagnosis. Shimizu S, Yatabe Y, Koshikawa T, Haruki N, Hatooka S, Shinoda M, Suyama M, Ogawa M, Hamajima N, Ueda R, Takahashi T, Mitsudomi T. Clin Cancer Res; 2000 Oct 01; 6(10):3994-9. PubMed ID: 11051248 [Abstract] [Full Text] [Related]
17. [Assessment of prognosis and p 53 mutations in patients with multiple tumors of the lung; intrapulmonary metastasis or double primary cancers?]. Osaki T, Oyama T, Takenoyama M, Taga S, So T, Yamashita T, Nakata S, Sugio K, Yasumoto K. Kyobu Geka; 2002 Jan 01; 55(1):25-9. PubMed ID: 11797404 [Abstract] [Full Text] [Related]
18. High frequency and heterogeneous distribution of p53 mutations in aflatoxin B1-induced mouse lung tumors. Tam AS, Foley JF, Devereux TR, Maronpot RR, Massey TE. Cancer Res; 1999 Aug 01; 59(15):3634-40. PubMed ID: 10446974 [Abstract] [Full Text] [Related]
19. Correlation of EGFR mutations with chromosomal alterations and expression of EGFR, ErbB3 and VEGF in tumor samples of lung adenocarcinoma patients. Reinmuth N, Jauch A, Xu EC, Muley T, Granzow M, Hoffmann H, Dienemann H, Herpel E, Schnabel PA, Herth FJ, Gottschling S, Lahm H, Steins M, Thomas M, Meister M. Lung Cancer; 2008 Nov 01; 62(2):193-201. PubMed ID: 18450321 [Abstract] [Full Text] [Related]
20. Patterns of EGFR, HER2, TP53, and KRAS mutations of p14arf expression in non-small cell lung cancers in relation to smoking history. Mounawar M, Mukeria A, Le Calvez F, Hung RJ, Renard H, Cortot A, Bollart C, Zaridze D, Brennan P, Boffetta P, Brambilla E, Hainaut P. Cancer Res; 2007 Jun 15; 67(12):5667-72. PubMed ID: 17575133 [Abstract] [Full Text] [Related] Page: [Next] [New Search]